Ledipasvir plus sofosbuvir: Hint of added benefit in further patient group

Documents subsequently submitted by the manufacturer show an advantage in sustained virologic response also for hepatitis C infection of genotype 1 with HIV coinfection without cirrhosis of the liver, reviewers report.
Source: ScienceDaily Headlines - Category: Science Source Type: news